Alpine Immune Sciences

+$0.24 (+3.00%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALPN and other ETFs, options, and stocks.

About ALPN

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies.

CEO

Mitchell H. Gold

Employees

Headquarters

Seattle, Washington

Founded

2007

ALPN Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

89.14K

High today

$8.29

Low today

$7.72

Open price

$8.12

Volume

68.78K

52 Week high

$14.40

52 Week low

$6.00

ALPN News

Simply Wall StMay 16

Insiders who bought in the last 12 months lose an additional US$65k as Alpine Immune Sciences, Inc. drops to US$229m

The recent 11% drop in Alpine Immune Sciences, Inc.'s ( ) stock could come as a blow to insiders who purchased US$268k worth of stock at an average buy price of

ALPN Earnings

-$0.55

-$0.37

-$0.18

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Estimated

-$0.19 per share

Actual

-$0.25 per share